Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts

Emilia Jaskula, PhD, Janusz Lange, MD PhD, Monika Mordak-Domagala, MD, Mariola Sedzimirska, MD PhD, Marta Lemieszewska, Agnieszka Tarnowska, Helena Pakos, Anna Sobczynska-Konefal, Andrzej Lange, MD

Blood (2019) 134 (Supplement_1): 5164.

https://doi.org/10.1182/blood-2019-130316

Published: 2019

Journal Articles

Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease

Emilia Jaskula, Andrzej Lange, MD, Mariola Sedzimirska, Jakub Chrustowicz, Agnieszka Tarnowska, Janusz Lange

Blood (2017) 130 (Supplement 1): 1420.

https://doi.org/10.1182/blood.V130.Suppl_1.1420.1420

Published: 2017

Journal Articles

Intra Bone Route of Donor Lymphocyte Infusions May Result with an Anti-Leukemic Effect Associated with an Accumulation of CD279+ Lymphocytes in the Marrow

Andrzej Lange, MD FRCP, Dr MDSci, Professor, Monika Mordak-Domagala, MD, Mariola Sedzimirska, MD PhD, Michalina Krydel, Helena Pakos, Jolanta Bochenska, Emilia Jaskula, PhD

Blood (2016) 128 (22): 5763.

https://doi.org/10.1182/blood.V128.22.5763.5763

Published: 2016

Journal Articles

Sorafenib Is Contributing to Salvage Chemotherapy and Is Effective Given Alone for Maintenance in AML FLT3 ITD Patients Relapsing Post Allo Hematopoietic Stem Cell Transplantation

Emilia Jaskula, PhD, Janusz Lange, MD PhD, Mariola Sedzimirska, MD PhD, Andrzej Lange, MD Dr MDSci., Professor

Blood (2014) 124 (21): 5265.

https://doi.org/10.1182/blood.V124.21.5265.5265

Published: 2014

Journal Articles

Essential Thrombocytosis Patients Have At Diagnosis Prevalence Of CD8+ and CD45RO+CCR7- Lymphocytes and High Proportions Of Double Positive IL-17+/CD15+ Cells In The Marrow Cell Population

Mariola Sedzimirska, MD, PhD, Aleksandra Klimczak, PhD, Emilia Jaskula, PhD, Dlubek Dorota, PhD, Andrzej Lange, MD, PhD

Blood (2013) 122 (21): 5261.

https://doi.org/10.1182/blood.V122.21.5261.5261

Published: 2013

Journal Articles

CMV and EBV Reactivation Post HSCT Impairs Survival of Patients If They Do Not Produce IgM Antibodies Againts These Viruses

Andrzej Lange, MD, DSci, Emilia Jaskula, PhD, Sylwia Mizia, MSci, Jolanta Bochenska, MSci, Janusz Lange, MD

Blood (2011) 118 (21): 4552.

https://doi.org/10.1182/blood.V118.21.4552.4552

Published: 2011

Journal Articles

HSCT PATIENTS with HHV6 Reactivation HAD LOW NUMBERS of CD4+ Effector Memory Lymphocytes IN BLOOD WHAT Associates with Rather POOR SURVIVAL.

Janusz Lange, MD, Daria Drabczak-Skrzypek, Dorota Dlubek, Emilia Jaskula, Dariusz Wolowiec, Andrzej Lange, MD

Blood (2010) 116 (21): 4555.

https://doi.org/10.1182/blood.V116.21.4555.4555

Published: 2010

Journal Articles

Gene Expression for Chemokine Receptors Influences Survival of Non-Hodgkin Lymphoma Patients

Grzegorz Mazur, Emilia Jaskula, Ilona Kryczek, Dorota Dlubek, Tomasz Wrobel, MD, PhD, Aleksandra Butrym, Andrzej Lange, MD, Kazimierz Kuliczkowski

Blood (2010) 116 (21): 3103.

https://doi.org/10.1182/blood.V116.21.3103.3103

Published: 2010

Journal Articles

HHV-6 Reactivation Lowers the Risk of Acute Graft-Versus-Host Disease but Enhances the Risk of Infections Due to Activation of CD4+FoxP3+ Lymphocytes.

Andrzej Lange, MD, PhD, Emilia Jaskula, Sylwia Madej, Dorota Dlubek, PhD

Blood (2009) 114 (22): 4653.

https://doi.org/10.1182/blood.V114.22.4653.4653

Published: 2009

Journal Articles

HHV6 and EBV Reactivations Associate with Encephalitis in Patients Post Allogeneic Haematopoietic Stem Cell Transplantation

Emilia Jaskula, Clinical Immunology, Agnieszka Tarnowska, Krzysztof Suchnicki, Andrzej Lange, MD

Blood (2008) 112 (11): 4352.

https://doi.org/10.1182/blood.V112.11.4352.4352

Published: 2008

Journal Articles

Increase in Proportion of Th-17 Lymphocytes in Blood Heralds Overt Acute Graft Versus Host Disease in HSCT Patients.

Andrzej Lange, MD, PhD, Dorota Dlubek, PhD, Emilia Jaskula, Daria Drabczak-Skrzypek, Mariola Sedzimirska, MD, PhD, Janusz Lange, MD

Blood (2008) 112 (11): 2226.

https://doi.org/10.1182/blood.V112.11.2226.2226

Published: 2008

Journal Articles

Increased Interleukin-17 Proportion in Helper T Cell (Th17) in Patients Post Allogeneic Hematopoietic Stem Cell Transplantation.

Andrzej Lange, Dorota Dlubek, PhD, Mariola Sedzimirska, Dr.med.Sci, Daria Drabczak-Skrzypek, MSci, Emilia Jaskula, MSci, Janusz Lange, MD

Blood (2007) 110 (11): 4971.

https://doi.org/10.1182/blood.V110.11.4971.4971

Published: 2007

Journal Articles

CCR5 and RANTES/CCL5 Gene Polymorphisms Affect the Risk of EBV Reactivations after Allogeneic HSCT.

Katarzyna Bogunia-Kubik, Anna Kuzyk, M.Sci., Emilia Jaskula, M.Sci., Andrzej Lange, MD

Blood (2006) 108 (11): 1262.

https://doi.org/10.1182/blood.V108.11.1262.1262

Published: 2006

Journal Articles

CCL2 Chemokine Gene Expression in Lymph Nodes May Have Prognostic Value in Non-Hodgkin’s Lymphoma.

Grzegorz Mazur, MD, PhD, Ilona Kryczek, PhD, Tomasz Wrobel, MD,PhD, Dorota Dlubek, MD,PhD, Aleksandra Klimczak, PhD, Emilia Jaskula, PhD, Michal Jelen, Andrzej Lange, Kazimierz Kuliczkowski

Blood (2006) 108 (11): 4644.

https://doi.org/10.1182/blood.V108.11.4644.4644

Published: 2006

Journal Articles

CCR5 Chemokine Receptor Expression Can Promote Disease Progression in Non-Hodgkin’s Lymphoma.

Grzegorz Mazur, MD, PhD, Ilona Kryczek, PhD, Tomasz Wrobel, MD,PhD, Dorota Dlubek, PhD, Aleksandra Klimczak, PhD, Emilia Jaskula, Michal Jelen, Andrzej Lange, Kazimierz Kuliczkowski

Blood (2006) 108 (11): 4645.

https://doi.org/10.1182/blood.V108.11.4645.4645

Published: 2006

Journal Articles

A High Proportion of CD4+CD25+ Lymphocytes Associates with a Risk of aGvHD and Inversely Correlate with Proportions of CMV and EBV Specific CD8+ Cells in Blood.

Andrzej Lange, PhD, MD, Dorota Dlubek, PhD, Daria Drabczak-Skrzypek, MSCi, Emilia Jaskula, MSCi, Dorota Duda, PhD

Blood (2006) 108 (11): 2855.

https://doi.org/10.1182/blood.V108.11.2855.2855

Published: 2006

Journal Articles

Low Dose Busulfan and ATG with Fludarabine as Conditioning Regimen Was Effective in Sibling and Unrelated Donor HSCT in CML Patients.

Andrzej Lange, PhD, MD, Mariola Sedzimirska, PhD, Dorota Dlubek, PhD, Emilia Jaskula, MSci, Anna Mlynarczewska, MSci, Agnieszka Sok, MSci

Blood (2006) 108 (11): 4808.

https://doi.org/10.1182/blood.V108.11.4808.4808

Published: 2006

Journal Articles

An Evidence That Mesenchymal Stem Cells Are Not Replaced by Peripheral Blood Stem Cell Allografts in CML Patients.

Andrzej Lange, Dorota Dlubek, Barbara Wysoczanska, Daria Drabczak-Skrzypek, Emilia Jaskula

Blood (2005) 106 (11): 4875.

https://doi.org/10.1182/blood.V106.11.4875.4875

Published: 2005

NARROW

Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts

Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease

Intra Bone Route of Donor Lymphocyte Infusions May Result with an Anti-Leukemic Effect Associated with an Accumulation of CD279+ Lymphocytes in the Marrow

Sorafenib Is Contributing to Salvage Chemotherapy and Is Effective Given Alone for Maintenance in AML FLT3 ITD Patients Relapsing Post Allo Hematopoietic Stem Cell Transplantation

Essential Thrombocytosis Patients Have At Diagnosis Prevalence Of CD8+ and CD45RO+CCR7- Lymphocytes and High Proportions Of Double Positive IL-17+/CD15+ Cells In The Marrow Cell Population

CMV and EBV Reactivation Post HSCT Impairs Survival of Patients If They Do Not Produce IgM Antibodies Againts These Viruses

HSCT PATIENTS with HHV6 Reactivation HAD LOW NUMBERS of CD4+ Effector Memory Lymphocytes IN BLOOD WHAT Associates with Rather POOR SURVIVAL.

Gene Expression for Chemokine Receptors Influences Survival of Non-Hodgkin Lymphoma Patients

HHV-6 Reactivation Lowers the Risk of Acute Graft-Versus-Host Disease but Enhances the Risk of Infections Due to Activation of CD4+FoxP3+ Lymphocytes.

HHV6 and EBV Reactivations Associate with Encephalitis in Patients Post Allogeneic Haematopoietic Stem Cell Transplantation

Increase in Proportion of Th-17 Lymphocytes in Blood Heralds Overt Acute Graft Versus Host Disease in HSCT Patients.

Increased Interleukin-17 Proportion in Helper T Cell (Th17) in Patients Post Allogeneic Hematopoietic Stem Cell Transplantation.

CCR5 and RANTES/CCL5 Gene Polymorphisms Affect the Risk of EBV Reactivations after Allogeneic HSCT.

CCL2 Chemokine Gene Expression in Lymph Nodes May Have Prognostic Value in Non-Hodgkin’s Lymphoma.

CCR5 Chemokine Receptor Expression Can Promote Disease Progression in Non-Hodgkin’s Lymphoma.

A High Proportion of CD4+CD25+ Lymphocytes Associates with a Risk of aGvHD and Inversely Correlate with Proportions of CMV and EBV Specific CD8+ Cells in Blood.

Low Dose Busulfan and ATG with Fludarabine as Conditioning Regimen Was Effective in Sibling and Unrelated Donor HSCT in CML Patients.

An Evidence That Mesenchymal Stem Cells Are Not Replaced by Peripheral Blood Stem Cell Allografts in CML Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only